Baltimore-Washington Financial Advisors’s Amgen AMGN Stock Holding History

Baltimore-Washington Financial Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$562K	Sell	1,552 -97	-6%	-$33.2K	0.02%	120
2026 Q1	$580K	Hold	1,649	–	–	0.03%	110
2025 Q4	$540K	Buy	1,649 +1	+0.1%	+$317	0.02%	113
2025 Q3	$465K	Buy	+1,648	New	+$478K	0.02%	119
2015 Q4	–	Sell	-1	Closed	–	–	97
2015 Q3	$0	Buy	+1	New	+$158	﹤0.01%	268
2015 Q1	–	Sell	-4	Closed	-$1K	–	301
2014 Q4	$1K	Hold	4	–	–	﹤0.01%	245
2014 Q3	$1K	Buy	+4	New	+$522	﹤0.01%	264
2013 Q4	–	Sell	-110	Closed	-$12K	–	306
2013 Q3	$12K	Sell	110 -34,140	-100%	-$3.7M	﹤0.01%	174
2013 Q2	$3.38M	Buy	+34,250	New	+$3.55M	1.46%	30

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Baltimore-Washington Financial Advisors's AMGN Position: Q2 2026 in Review

Baltimore-Washington Financial Advisors reduced its Amgen (AMGN) stake by 5.9% in Q2 2026, selling an estimated $33.2K and leaving 1,552 shares worth $562K. The position accounts for 0.02% of the portfolio, ranked #120.

Baltimore-Washington Financial Advisors first reported a position in AMGN in Q2 2013 and has held it in 9 quarters since. The position peaked at $3.38M in Q2 2013. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Baltimore-Washington Financial Advisors held 1,552 shares of Amgen worth $562K as of Q2 2026.
Baltimore-Washington Financial Advisors sold 97 Amgen shares in Q2 2026, an estimated $33.2K.
Amgen made up 0.02% of Baltimore-Washington Financial Advisors's portfolio in Q2 2026, its #120 holding.
Baltimore-Washington Financial Advisors first reported a position in Amgen in Q2 2013 and has held it in 9 quarters since.
Baltimore-Washington Financial Advisors's Amgen position peaked at $3.38M in Q2 2013.
3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Baltimore-Washington Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.